We are live on
!
Find out more
Nautilus Biotechnolgy
NAUT
NAUT
83 hedge funds and large institutions have $183M invested in Nautilus Biotechnolgy in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 13 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
77% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 13
22% more capital invested
Capital invested by funds: $150M → $183M (+$33.2M)
8% more funds holding
Funds holding: 77 → 83 (+6)
0.09% more ownership
Funds ownership: 51.09% → 51.18% (+0.09%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
83
Holders Change
+6
Holders Change %
+7.79%
% of All Funds
1.19%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
8
Increased
23
Reduced
13
Closed
2
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
-$1K
Top Buyers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$303K |
| 2 |
Goldman Sachs
New York
|
+$206K |
| 3 |
Morgan Stanley
New York
|
+$204K |
| 4 |
Barclays
London,
United Kingdom
|
+$122K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$111K |
Top Sellers
| 1 |
BlackRock
New York
|
-$679K |
| 2 |
Bank of New York Mellon
New York
|
-$94.8K |
| 3 |
Jane Street
New York
|
-$64.8K |
| 4 |
CC
Clearline Capital
New York
|
-$51.5K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$29.8K |
